Trace Neuroscience
@TraceNeuro
Followers
100
Following
11
Media
16
Statuses
20
On a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases
South San Francisco, CA
Joined October 2024
Sometimes, committing to impacting those with #ALS means getting ice water dumped on us. We recently partnered with @youralsnetwork to sponsor #SplashToCureALS. CEO @ercgrn, COO Megan Baierlein & CBO/CSO @NMordwinkin helped to raise awareness and drop their body temperatures. 🧊
0
2
3
Our employees and their families have been all over the map this summer! From exploring Newport to hiking in Colorado and relaxing by the lake in Tahoe, an opportunity to recharge was well-deserved for our dedicated team. Check out some of our favorite shots from coast to coast.
0
0
1
Happy #Pride! This June, we proudly celebrate Pride Month and stand with the LGBTQ+ community. At Trace, we believe that diversity makes us stronger, and we are committed to fostering a workplace and broader community where everyone feels seen, valued and respected. 🌈
1
0
1
Fatal neurodegenerative diseases like ALS don't discriminate. Tomorrow on #GlobalALSAwarenessDay we join our peers in advocating for better research, advanced therapies & ultimately, hope for those affected by this diagnosis. Learn more from @ALSMNDAlliance. #ALSMNDWithoutBorders
0
1
2
CBO/CSO @nmordwinkin will be on the East Coast for #BIO2025 this week! We look forward to the opportunity to connect with #biotech and #neuro peers, old and new. See you soon.
0
1
1
CEO @ercgrn & CBO/CSO @nmordwinkin will join the #neuroscience community at the H.C. Wainwright Neuro Perspectives conference next week. Join us at this hybrid event:
0
1
1
"Precision separates expert from novice, health from disease and success from failure in drug development." CEO @ercgrn sat down with new Harvard M.D.-Ph.D. grad @dylanvneel to discuss our vision for reshaping the #ALS and neurodegenerative disease treatment landscape. ⬇️.
Biomarker interview with Dr. Eric Green, CEO of @TraceNeuro. Eric and his team are developing a promising targeted therapy for #ALS. Check it out! #neurology #biotech .
0
0
1
At Trace, we think every person should have access to proper treatment for their disease, including those with #ALS. On #LouGehrigDay, we join @NPLB_org in their mission to make medicines affordable for every patient in America. @ercgrn joins fellow biotech leaders to share more.
ALS is relentless. So are the patients and research teams fighting it. For the 30,000+ Americans living with amyotrophic lateral sclerosis, every day matters. New treatments are on the horizon!. 🎥 #ALS #ALSAwareness #FixInsurance #Biotech #Innovation
0
2
6
CBO/CSO Nick Mordwinkin will join @UofCalifornia for their Reinvigorating Innovation in #ALS symposium tomorrow! This will be an interactive event, maximizing the UC system-wide ALS expertise with physicians, biomedical researchers, engineers & scientists.
0
0
1
This week, Terry Fang will join other #ALS industry experts at the #ALSDrugDevelopment Summit! Find her during Day 2 on the Clinical & Translational Utility Track. For more details, check out the ALS Drug Development Summit agenda.
0
0
1
Trace scientists Shila Mekhoubad and Ryan Morrie look forward to sharing insight into our work on UNC13A expression and its relation to ALS during the @TargetALS_fdn annual meeting this week. Learn more:
0
0
2
May is #ALSAwarenessMonth. 1 in every 400 people worldwide will be diagnosed with ALS their lifetime. This month, we join our community in raising awareness of both the devastating effects of this debilitating disease & the need for new treatment options for those living with it.
0
0
1
Trace CMO Irina Antonijevic looks forward to sharing experience from three decades of working in psychiatry and neurology drug development during the #CMO360Summit Rare Disease roundtable next week. Learn more about the summit and register to attend here.
0
0
1
We're excited to begin a new partnership with @UnlearnAI to utilize their Digital Twin Generator for #ALS & the Unlearn Platform as we plan our upcoming Phase 1/2 clinical trial in ALS. Read more from CEO @ercgrn below & here:
0
1
3
This weekend, we were honored to attend the @alsone_official Snowball Gala. The annual Snowball supports critical #ALS research & care for patients & their loved ones. We had an inspiring evening celebrating the strength of those impacted by this disease.
0
0
1
RT @timmermanreport: How Maze Therapeutics Navigated Genetics-based Drug Discovery. By co-founder and former CSO Eric Green. (Sub. Req.) ht….
timmermanreport.com
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting,...
0
5
0
Don't miss our CBO/CSO Nick Mordwinkin at the Neuroscience Innovation Pharma Partnering Summit in Boston February 18-19. Nick will join other astute industry leaders for conversation on all things #neuroscience & #biotech strategy.
0
0
1
Members of our team recently enjoyed an evening at the @youralsnetwork's 2025 Champions for Cures & Care Gala. This event celebrates extraordinary individuals & organizations whose contributions & efforts advance the ALS Network's mission-critical activities for those with #ALS.
0
0
3
Check it out! Our founder and CEO Eric Green recently joined #TheGeneticsPodcast to chat about his journey to Trace - from his time in cardiology to honing in on #genetic modifiers to discover new therapies for #ALS. Listen below. ⬇️.
Episode 166 of #TheGeneticsPodcast is here! 🚀. Listen in to hear Eric Green, Founder and CEO of @TraceNeuro and @MazeInBiotech .discuss developing targeted #GeneTherapies for #ALS. 🎧 📽️ #SanoGenetics
0
0
4
1 in 400 people around the world will be diagnosed w/ #ALS in their lifetime. Meet Trace - on a mission to expand the promise of genomic medicine for those w/ neurodegenerative diseases, re-establishing healthy communication between nerves & muscle cells.
1
7
14